Lan‐Qing Yao

702 total citations
38 papers, 319 citations indexed

About

Lan‐Qing Yao is a scholar working on Hepatology, Epidemiology and Cancer Research. According to data from OpenAlex, Lan‐Qing Yao has authored 38 papers receiving a total of 319 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Hepatology, 18 papers in Epidemiology and 17 papers in Cancer Research. Recurrent topics in Lan‐Qing Yao's work include Hepatocellular Carcinoma Treatment and Prognosis (28 papers), Liver Disease Diagnosis and Treatment (17 papers) and Cancer, Lipids, and Metabolism (13 papers). Lan‐Qing Yao is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (28 papers), Liver Disease Diagnosis and Treatment (17 papers) and Cancer, Lipids, and Metabolism (13 papers). Lan‐Qing Yao collaborates with scholars based in China, United States and Hong Kong. Lan‐Qing Yao's co-authors include Ming-Da Wang, Wan Yee Lau, Yong‐Kang Diao, Feng Shen, Tian Yang, Timothy M. Pawlik, Chao Li, Li‐Yang Sun, Ya-Hao Zhou and Ting‐Hao Chen and has published in prestigious journals such as Advanced Materials, SHILAP Revista de lepidopterología and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Lan‐Qing Yao

32 papers receiving 314 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lan‐Qing Yao China 10 227 137 99 66 57 38 319
Yong‐Kang Diao China 11 252 1.1× 144 1.1× 88 0.9× 86 1.3× 82 1.4× 42 362
Vennis Lourdusamy United States 5 172 0.8× 97 0.7× 58 0.6× 67 1.0× 102 1.8× 16 320
Mariella Di Marco Italy 4 280 1.2× 223 1.6× 74 0.7× 39 0.6× 65 1.1× 5 379
Claudia Campani Italy 11 149 0.7× 111 0.8× 58 0.6× 47 0.7× 76 1.3× 41 301
Rongyun Mai China 10 154 0.7× 143 1.0× 57 0.6× 44 0.7× 63 1.1× 24 305
Marco Sanduzzi‐Zamparelli Spain 10 268 1.2× 233 1.7× 61 0.6× 40 0.6× 78 1.4× 30 424
Shu‐Yein Ho Taiwan 14 347 1.5× 253 1.8× 93 0.9× 42 0.6× 91 1.6× 31 407
Cheng‐Qian Zhong China 9 139 0.6× 71 0.5× 77 0.8× 36 0.5× 47 0.8× 20 277
Eriko Iguchi Japan 13 219 1.0× 162 1.2× 54 0.5× 35 0.5× 57 1.0× 28 337
P. Merle United States 3 195 0.9× 99 0.7× 79 0.8× 44 0.7× 60 1.1× 5 333

Countries citing papers authored by Lan‐Qing Yao

Since Specialization
Citations

This map shows the geographic impact of Lan‐Qing Yao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lan‐Qing Yao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lan‐Qing Yao more than expected).

Fields of papers citing papers by Lan‐Qing Yao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lan‐Qing Yao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lan‐Qing Yao. The network helps show where Lan‐Qing Yao may publish in the future.

Co-authorship network of co-authors of Lan‐Qing Yao

This figure shows the co-authorship network connecting the top 25 collaborators of Lan‐Qing Yao. A scholar is included among the top collaborators of Lan‐Qing Yao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lan‐Qing Yao. Lan‐Qing Yao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yao, Lan‐Qing, Lei Cai, Kongying Lin, et al.. (2025). Impact of compliance to postoperative regular follow-up on long-term prognosis after curative resection for hepatocellular carcinoma: A multicenter analysis. Hepatobiliary & pancreatic diseases international. 24(3). 261–268. 1 indexed citations
5.
Wang, Ming-Da, Yong‐Kang Diao, Lan‐Qing Yao, et al.. (2024). Emerging role of molecular diagnosis and personalized therapy for hepatocellular carcinoma. PubMed. 3(1). 100083–100083. 11 indexed citations
6.
Ouyang, Wei, Wanyin Wang, Chao Li, et al.. (2023). Hydroxymethylation and Epigenetic Drugs: New Insights into the Diagnosis and Treatment in Epigenetics of Hepatocellular Carcinoma. Journal of Oncology. 2023. 1–8. 1 indexed citations
7.
Yao, Lan‐Qing, Chao Li, Yong‐Kang Diao, et al.. (2023). Grading severity of microscopic vascular invasion was independently associated with recurrence and survival following hepatectomy for solitary hepatocellular carcinoma. HepatoBiliary Surgery and Nutrition. 13(1). 16–28. 8 indexed citations
10.
Li, Chao, Zhi-Peng Liu, Li‐Yang Sun, et al.. (2023). Novel online calculator to predict reduced risk of early recurrence from adjuvant transarterial chemoembolisation for patients with hepatocellular carcinoma. SHILAP Revista de lepidopterología. 1(1). e100008–e100008. 5 indexed citations
11.
Liu, Siyu, Li‐Yang Sun, Lan‐Qing Yao, et al.. (2022). Diagnostic Performance of AFP, AFP-L3, or PIVKA-II for Hepatitis C Virus-Associated Hepatocellular Carcinoma: A Multicenter Analysis. Journal of Clinical Medicine. 11(17). 5075–5075. 23 indexed citations
12.
13.
Shi, Hongyun, Chao Li, Zhengliang Chen, et al.. (2022). Association of Adjuvant Radiation Therapy With Long-Term Overall and Recurrence-Free Survival After Hepatectomy for Hepatocellular Carcinoma: A Multicenter Propensity-Matched Study. International Journal of Radiation Oncology*Biology*Physics. 114(2). 238–249. 5 indexed citations
14.
Liu, Zhi-Peng, Lan‐Qing Yao, Yong‐Kang Diao, et al.. (2022). Association of Preoperative Body Mass Index with Surgical Textbook Outcomes Following Hepatectomy for Hepatocellular Carcinoma: A Multicenter Study of 1206 Patients. Annals of Surgical Oncology. 29(7). 4278–4286. 18 indexed citations
15.
Yao, Lan‐Qing, Zhengliang Chen, Yong‐Kang Diao, et al.. (2022). Clinical Features of Recurrence After Hepatic Resection for Early-Stage Hepatocellular Carcinoma and Long-Term Survival Outcomes of Patients with Recurrence: A Multi-institutional Analysis. Annals of Surgical Oncology. 29(7). 4291–4303. 45 indexed citations
16.
Liu, Siyu, Chao Li, Li‐Yang Sun, et al.. (2022). ASAP Score versus GALAD Score for detection of hepatitis C-related hepatocellular carcinoma: A multicenter case-control analysis. Frontiers in Oncology. 12. 1018396–1018396. 21 indexed citations
17.
Yan, Wentao, Chao Li, Lan‐Qing Yao, et al.. (2021). Predictors and long-term prognosis of early and late recurrence for patients undergoing hepatic resection of hepatocellular carcinoma: a large-scale multicenter study. HepatoBiliary Surgery and Nutrition. 12(2). 155–168. 29 indexed citations
19.
Gao, Cheng, et al.. (2021). Low expression of AQP9 and its value in hepatocellular carcinoma. Translational Cancer Research. 10(4). 1826–1841. 6 indexed citations
20.
Chen, Weipeng, et al.. (2021). The expression and prognostic value of REXO4 in hepatocellular carcinoma. Journal of Gastrointestinal Oncology. 12(4). 1704–1717. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026